ANI Pharmaceuticals announces cash offer to acquire Egetis TherapeuticsNov 5M&AAni Pharmaceuticals Inc
Harmony Biosciences posts Q3 results, highlights BP-205 safety dataNov 4Quarterly updateAni Pharmaceuticals IncHarmony Biosciences Holdings, Inc.
FDA approves three generic drug applications, four submissions, across Amneal and ANI PharmsOct 15Weekly roundup, 3 itemsAmneal Pharmaceuticals, LLCAni Pharmaceuticals Inc
ANI Pharmaceuticals adds Henry Gosebruch to board, Shanmugam resigns directorshipAug 24PeopleAni Pharmaceuticals Inc
ANI Pharmaceuticals posts record Q2 2026, trims Cortrophin Gel outlookAug 7Quarterly updateAni Pharmaceuticals Inc